Vertebrate Antibodies

Vertebrate Antibodies Limited (VAL) is a biotech spinout company from the University of Aberdeen with a focus on the development of antibodies to targets within a wide range of organisms for research and clinical applications. VAL supports the life sciences community by providing and developing a large range of high quality antibodies. VAL’s antibodies will be developed for high performance within a range of downstream applications including: Western Blotting, Immunohistochemistry, Immunofluorescence, ELISA and Flow Cytometry. Antibodies will be designed to specifically target key cellular components relevant to cancer, immunological disorders, neurobiology and disease across different species.